Skip to main content

View full-text article in PMC

. 2022 Jun 16;14(12):2436. doi: 10.3390/polym14122436

Table 3.

Microbiological activity of examined formulations counter to different bacterial strains.

Bacterial Type	Inhibition Zone (cm)
Bacterial Type	FA-SLN-Gel	Placebo-SLN-Hydrogel	Marketed FA (Fucidin^®)
Bacillus subtilis	3.04 ± 0.14 *#	2.05 ± 0.14 *	2.73 ± 0.11 #
Staphylococcus aureus	4.27 ± 0.11 *#	3.84 ± 0.11 *	4.02 ± 0.10 #
Klebsiella pneumoniae	2.52 ± 0.13 *#	2.14 ± 0.15 *	1.12 ± 0.11 #

Values are expressed as mean ± SD, n = 3. * (p < 0.05) compared to Fucidin^®; and # (p < 0.05) compared to placebo formulation.